Ten-Year Study Tracks Deferiprone-Induced Neutropenia Risks in Adult Thalassemia
A ten-year study of 654 adult thalassemia patients reveals deferiprone-associated neutropenia occurs primarily within the first six months of treatment.
A ten-year study of 654 adult thalassemia patients reveals deferiprone-associated neutropenia occurs primarily within the first six months of treatment.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.